Xeomin
Xeomin is a Botox developed by Merz Pharmaceuticals in Germany, approved by 23 countries, including the FDA in the U.S. and EMA in Europe, and has proven safety. It is the first to use pure botulinum toxin by removing complex proteins, which reduces the formation of antibodies and greatly lowers the risk of resistance.
- #World's First Pure Toxin
- #Long-lasting Effect
- #Safety
- #Reduced Risk of Resistance